Aktieanalys

NextCell Pharma: Interim data around the corner - Redeye

{newsItem.title}

Redeye Publicerad: 03 Apr 10:31

NextCell Pharma

Redeye comments on NextCell Pharma ahead of the upcoming interim data from ProTrans-Young, set to be presented in connection with the IDF World Diabetes Congress in Bangkok next week—a potential near-term catalyst for the share.

Länk till analysen i sin helhet: https://www.redeye.se/research/1092139/nextcell-pharma-interim-data-around-the-corner?utm_source=finwire&utm_medium=RSS

Nyheter om NextCell Pharma

Läses av andra just nu

Om aktien NextCell Pharma

Senaste nytt